FRAS1 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "FRAS1" in English language version.

refsWebsite

Global rank English rank

4^th place

2^nd place

1,626^th place

1,007^th place

11^th place

8^th place

low place

doi.org

McGregor L, Makela V, Darling SM, Vrontou S, Chalepakis G, Roberts C, et al. (June 2003). "Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein". Nature Genetics. 34 (2): 203–208. doi:10.1038/ng1142. PMID 12766769. S2CID 1018128.
Wang V, Geybels MS, Jordahl KM, Gerke T, Hamid A, Penney KL, et al. (July 2021). "A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer". The Prostate. 81 (10): 683–693. doi:10.1002/pros.24148. PMC 8491321. PMID 33956343.
Wang V, Geybels MS, Jordahl KM, Gerke T, Hamid A, Penney KL, et al. (July 2021). "A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer". The Prostate. 81 (10): 683–693. doi:10.1002/pros.24148. PMC 8491321. PMID 33956343.

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: Fraser syndrome 1".
Wang V, Geybels MS, Jordahl KM, Gerke T, Hamid A, Penney KL, et al. (July 2021). "A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer". The Prostate. 81 (10): 683–693. doi:10.1002/pros.24148. PMC 8491321. PMID 33956343.
Li, Chumei; Slavotinek, Anne (1993), Adam, Margaret P.; Ardinger, Holly H.; Pagon, Roberta A.; Wallace, Stephanie E. (eds.), "FREM1 Autosomal Recessive Disorders", GeneReviews®, Seattle (WA): University of Washington, Seattle, PMID 20301721, retrieved 2021-11-23
Wang V, Geybels MS, Jordahl KM, Gerke T, Hamid A, Penney KL, et al. (July 2021). "A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer". The Prostate. 81 (10): 683–693. doi:10.1002/pros.24148. PMC 8491321. PMID 33956343.

McGregor L, Makela V, Darling SM, Vrontou S, Chalepakis G, Roberts C, et al. (June 2003). "Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein". Nature Genetics. 34 (2): 203–208. doi:10.1038/ng1142. PMID 12766769. S2CID 1018128.
Wang V, Geybels MS, Jordahl KM, Gerke T, Hamid A, Penney KL, et al. (July 2021). "A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer". The Prostate. 81 (10): 683–693. doi:10.1002/pros.24148. PMC 8491321. PMID 33956343.
Li, Chumei; Slavotinek, Anne (1993), Adam, Margaret P.; Ardinger, Holly H.; Pagon, Roberta A.; Wallace, Stephanie E. (eds.), "FREM1 Autosomal Recessive Disorders", GeneReviews®, Seattle (WA): University of Washington, Seattle, PMID 20301721, retrieved 2021-11-23
Wang V, Geybels MS, Jordahl KM, Gerke T, Hamid A, Penney KL, et al. (July 2021). "A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer". The Prostate. 81 (10): 683–693. doi:10.1002/pros.24148. PMC 8491321. PMID 33956343.

McGregor L, Makela V, Darling SM, Vrontou S, Chalepakis G, Roberts C, et al. (June 2003). "Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein". Nature Genetics. 34 (2): 203–208. doi:10.1038/ng1142. PMID 12766769. S2CID 1018128.